News & Events.

  • Filters

  • Reset
6 July 2022

Phytolon closes $14.5 million Series A round

Portfolio company Phytolon, a developer of fermentation-based natural food colors, announced it has secured $14.5 million in funding, led by DSM Venturing, to...
7 June 2022

Bayer Trendlines Ag Innovation Fund co-invests with Trendlines in TierraSpec

Cost-effective and remote quantification of carbon content in agricultural soil

16 May 2022

Limaca Medical and HekaBio announce Japan partnership

The partnership aims to advance precision medicine

3 May 2022

Limaca Medical receives FDA breakthrough device designation

Limaca’s Precision-GI endoscopic biopsy device advances precision medicine

7 April 2022

Escala Medical receives FDA regulatory clearance

First in Human study completed; internationally renowned urogynecologist Mickey Karram, MD, joins SAB

21 March 2022

Arcuro Medical names new medical director and SAB member

Dr. Phil Davidson named medical director and chair of the Arcuro SAB, Dr. Ken Zaslav joins SAB as founding member

28 February 2022

Phytolon and Ginkgo Bioworks collaborate on production of vibrant food colors

The companies seek to leverage cell programming to produce betalain pigments across the yellow-to-purple spectrum

8 February 2022

Vensica closes $19 million investment round

Vensica's minimally invasive solutions unlock the potential of neurotoxins in urology

26 January 2022

SetBone Medical announces $1.6 million financing

SetBone Medical has developed a novel bone cement for the treatment of spinal vertebrae fractures

Skip to content